Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
Palantir Technologies recently reported stellar fourth-quarter financial results that propelled its market value to $230 billion. Hans Mosesmann at Rosenblatt Securities recently reiterated his AMD ...